Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SHINE Study: An Open Label, Interventional, Multicentre, Prospective Feasibility Study, Designed to Evaluate the Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

NCT05597605 is registered in ClinicalTrials.gov with Indigo Diabetes NV as lead sponsor.

NCT NCT05597605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SHINE Study: An Open Label, Interventional, Multicentre, Prospective Feasibility Study, Designed to Evaluate the Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects
Lead sponsor
Indigo Diabetes NV
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2022
Completion date
January 23, 2024
Enrollment
6 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetes mellitus, type 1, diabetes mellitus, type 2, hyperglycaemia (diabetic), hypoglycemia, ketoacidosis, diabetic